Results 151 to 160 of about 278,652 (177)
Some of the next articles are maybe not open access.
Clinical Genetics
To determine the prevalence of CHD7, FGFR1 and ANOS1 variants and the impacts of their splicing variants on mis‐splicing in patients with congenital hypogonadotropic hypogonadism (CHH).
Yuting Li +10 more
semanticscholar +1 more source
To determine the prevalence of CHD7, FGFR1 and ANOS1 variants and the impacts of their splicing variants on mis‐splicing in patients with congenital hypogonadotropic hypogonadism (CHH).
Yuting Li +10 more
semanticscholar +1 more source
Journal of Pediatric Endocrinology & Metabolism (JPEM)
Objectives Congenital hypogonadotropic hypogonadism (CHH) is a rare condition caused by a defect in the production, secretion or action of gonadotropin-releasing hormone.
Xiao-Qian Chen +8 more
semanticscholar +1 more source
Objectives Congenital hypogonadotropic hypogonadism (CHH) is a rare condition caused by a defect in the production, secretion or action of gonadotropin-releasing hormone.
Xiao-Qian Chen +8 more
semanticscholar +1 more source
Andrology
Limited data are available regarding the fertility‐inducing treatment outcomes and spermatogenic duration in congenital hypogonadotropic hypogonadism patients carrying prokineticin receptor 2 rare sequence variants.
Yuhan Wang +7 more
semanticscholar +1 more source
Limited data are available regarding the fertility‐inducing treatment outcomes and spermatogenic duration in congenital hypogonadotropic hypogonadism patients carrying prokineticin receptor 2 rare sequence variants.
Yuhan Wang +7 more
semanticscholar +1 more source
What Are the Pharmacological Considerations for Male Congenital Hypogonadotropic Hypogonadism?
Expert Opinion on Pharmacotherapy, 2022Giulia Rastrelli +2 more
exaly
Management of Congenital Hypogonadotropic Hypogonadism in Females
Human Fertility, 2023Cheryl Fitzgerald
exaly

